Drug intelligence / Profile preview

Eleview

Development stage
Phase 4
Lead developer
Cosmo Pharmaceuticals
Modality
Device-based Delivery → Drug Delivery Systems
Administration
Submucosal
01

Overview

Eleview is a submucosal injectable composition used in gastrointestinal endoscopic procedures. It is designed to lift polyps, adenomas, early-stage cancers, or other gastrointestinal mucosal lesions prior to excision with a snare or other endoscopic device. Key features and benefits include: * Forms an immediate cushion of optimal shape, height, and duration * Contains methylene blue as a contrast dye for improved visibility of lesion margins * Provides a long-lasting cushion with >45 minute lifting time * Requires less volume and fewer reinjections compared to saline * Pre-mixed, sterile, and ready to use * Low-viscosity emulsion that fits through a 23G needle and is easy to inject Eleview's component ingredients include Water for injection, Medium-chain triglycerides, Poloxamer 188, Polyoxyl-15-hydroxystearate, Sodium chloride, and Methylene blue. The formulation is characterized by strong bioadhesive properties, likely due to the interaction of its components with the structure of the extracellular matrix, allowing it to structure itself in contact with the submucosa. A randomized, double-blind clinical study comparing Eleview with normal saline (with methylene blue) in EMR for large (≥2 cm) colorectal polyps showed statistically significant improvement (p < 0.001) in total volume needed for resection, volume per lesion size, initial injected volume, and Sidney Resection Quotient. The study also showed positive trends for lower resection time, fewer resection pieces, and higher en bloc resection rates compared to normal saline. Eleview contains a very low amount of methylene blue (0.5 mg at the maximum recommended volume of 50 mL).

Brand names
Eleview
Other names
SIC-8000SIC8000SIC 8000Eleview

Beyond the preview

Go deeper on Eleview.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eleview.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call